Doctors want more training to recommend cannabis as opioid alternative

This study examines physicians' experiences with Illinois' Opioid Alternative Patient Program (OAPP), which certifies doctors to recommend cannabis as an alternative to opioids. The research surveyed 199 physicians participating in the program, revealing mixed attitudes about cannabis as an opioid replacement. While doctors and patients both recognize the need for alternatives to opioids and support exploring cannabis as an option, the findings highlight significant gaps in medical knowledge. Physicians expressed concern about their own lack of training and education to confidently guide patients, particularly regarding which patients would benefit most from cannabis and how to integrate it into broader pain management strategies.

A critical concern emerged around the role of dispensary staff acting as proxy clinicians—essentially providing medical advice without formal medical training or credentials. This practice raises serious questions about patient safety and the quality of guidance patients receive when choosing cannabis products. The research identifies this as a key implementation barrier that must be addressed for the program to function effectively and safely. Participants strongly desired more structured education and training programs to help them understand cannabis pharmacology, appropriate patient selection, dosing considerations, and how to have informed conversations with patients about cannabis use.

The findings underscore an important reality: while cannabis may offer genuine benefits as an opioid alternative, successful implementation requires more than just legal access. For this approach to gain wider acceptance among healthcare providers and maximize benefits for patients, the medical community needs robust training, more rigorous research on cannabis efficacy and safety, and strategies to reduce stigma around both cannabis and opioid use disorders. Without these elements, the potential of cannabis as a therapeutic alternative remains underutilized, and patients may receive suboptimal guidance.